SR-4133

N/A

Report date: 2023/05/29 15:32:29
NME

Base Information

Drug NameSR-4133
Drug Alias NameSR-4133
ClassificationSmall molecules
Mechanisms of ActionCasein kinase I isoform epsilon inhibitors
TargetsCasein kinase I isoform epsilon
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Scripps Research Institute Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A